The aim of this study is to complement ongoing burden assessment research with prospective surveillance of LRTI hospitalizations attributable to RSV, including the resulting complications and impact on cost-effectiveness. In addition, co-circulating viral pathogens that cause LRTI, such as human metapneumovirus (HMPV) and SARS-Cov2, will be analyzed.
